Clonal tracing reveals diverse patterns of response to immune checkpoint blockade
Abstract Background Immune checkpoint blockade (ICB) therapy has improved patient survival in a variety of cancers, but only a minority of cancer patients respond. Multiple studies have sought to identify general biomarkers of ICB response, but elucidating the molecular and cellular drivers of resis...
Huvudupphovsmän: | , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Materialtyp: | Artikel |
Språk: | English |
Publicerad: |
BMC
2020-10-01
|
Serie: | Genome Biology |
Ämnen: | |
Länkar: | http://link.springer.com/article/10.1186/s13059-020-02166-1 |